Circuit Court Upholds PTAB Ruling Invalidating Daiichi Sankyo Patents

Drug Industry Daily
A A
The Federal Circuit upheld the Patent Trial and Appeal Board’s invalidation of Daiichi Sankyo’s patents for the anti-clotting drug Effient (prasugrel).

To View This Article:

Login

Subscribe To Drug Industry Daily